Embecta Corp.'s Board of Directors has declared a quarterly cash dividend of $0.01 per share of common stock. The dividend will be paid on June 15, 2026, to shareholders recorded by the close of business on May 28, 2026. This move reflects Embecta's ongoing commitment to returning value to its shareholders as it continues to grow as a global medical supplies company focused on insulin delivery and innovative healthcare solutions.
Alamar Biosciences presented extensive data from its NULISA platform at the AAIC 2026 conference, highlighting advances in blood-based biomarkers for Alzheimer's detection and staging. The company emphasized new findings on eMTBR-Tau and BD-pTau217, ...
Alamar Biosciences announced that its NULISA platform was prominently featured in over 140 scientific presentations at the 2026 Alzheimer's Association International Conference (AAIC) in London, highlighting its growing adoption in Alzheimer's resear...
Easterly Government Properties was downgraded from 'strong buy' to 'buy' as its share price had outpaced the company's fundamentals, though its valuation remains attractive. The company reported strong Q1 2026 results, with revenue up 16% and core FF...
Fidelity reports that speculative investors, often called 'fast money,' are quickly pulling out of cryptocurrencies like Bitcoin and precious metals. This capital is rotating into the semiconductor sector, signaling a shift in market focus towards te...
Holtec Nuclear Corporation has filed a registration statement with the U.S. SEC for a proposed initial public offering (IPO) of its Class A common stock, planning to list on Nasdaq under the symbol "HNUC." The offering details, including share count ...
